Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy XBiotech stock
Learn how to easily invest in XBiotech stock.
XBiotech is a biotechnology business based in the US. XBiotech shares (XBIT) are listed on the NASDAQ and all prices are listed in US Dollars. XBiotech employs 93 staff and has a trailing 12-month revenue of around $8.2 million.
How to buy XBiotech stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – XBIT. It's that simple.
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- Get $10 when you sign up and deposit $100
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
XBiotech stock price (NASDAQ: XBIT)Use our graph to track the performance of XBIT stocks over time.
XBiotech shares at a glance
|Latest market close||$4.30|
|52-week range||$3.00 - $10.96|
|50-day moving average||$3.51|
|200-day moving average||$4.79|
|Wall St. target price||$18.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.67|
Buy XBiotech stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy XBiotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
XBiotech price performance over time
|1 week (2023-01-19)||4.12%|
|1 month (2022-12-23)||39.61%|
|3 months (2022-10-26)||17.81%|
|6 months (2022-07-26)||-16.18%|
|1 year (2022-01-22)||N/A|
|2 years (2021-01-26)||-76.84%|
|3 years (2020-01-24)||23.2|
|5 years (2018-01-26)||4.73|
|Revenue TTM||$8.2 million|
|Gross profit TTM||$12.6 million|
|Return on assets TTM||-7.9%|
|Return on equity TTM||-13.94%|
|Market capitalisation||$131.2 million|
TTM: trailing 12 months
XBiotech share dividends
We're not expecting XBiotech to pay a dividend over the next 12 months.
XBiotech share price volatility
Over the last 12 months, XBiotech's shares have ranged in value from as little as $3 up to $10.96. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while XBiotech's is 1.0886. This would suggest that XBiotech's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
XBiotech Inc. , a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas. .
XBiotech in the news
XBiotech (NASDAQ:XBIT) Is In A Good Position To Deliver On Growth Plans
Frequently asked questionsWhat percentage of XBiotech is owned by insiders or institutions?
Currently 35.362% of XBiotech shares are held by insiders and 13.939% by institutions. How many people work for XBiotech?
Latest data suggests 93 work at XBiotech. When does the fiscal year end for XBiotech?
XBiotech's fiscal year ends in December. Where is XBiotech based?
XBiotech's address is: 5217 Winnebago Lane, Austin, TX, United States, 78744 What is XBiotech's ISIN number?
XBiotech's international securities identification number is: CA98400H1029 What is XBiotech's CUSIP number?
XBiotech's Committee on Uniform Securities Identification Procedures number is: 98400H102
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert